Lannett Company Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.91B |
| AUROPHARMA | Aurobindo Pharma | Outperform |
18
|
Rp1.15k | Rp1.09k | 1.95% | 20 | Rp675.88B |
| APN | Aspen Pharmacare Holdings | Outperform |
18
|
R224.27 | R202.49 | 3.51% | 1 | R99.79B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.35 | £28.11 | 50.96% | 9 | £4.27B |
| RICHTER | Outperform |
18
|
Ft9.34k | Ft11.02k | 25.27% | 2 | Ft1.71T | |
| PRGO | Perrigo Co PLC | Buy |
16
|
$32.90 | $44.75 | 20.36% | 0 | $4.43B |
| KRKG | Krka, d. d. | Buy |
18
|
126.00€ | 119.80€ | 13.10% | 0 | 3.88€B |
| GLENMARK | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.06k | Rp767.80 | -14.44% | 9 | Rp298.33B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.08 | $69.00 | 47.34% | 0 | $2.02B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.12 | $6.13 | 22.55% | 1 | $1.87B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.08 | $41.00 | 32.98% | 0 | $1.65B |
| AIP | Adcock Ingram Holdings | Hold |
16
|
R55.69 | R55.97 | 0.56% | 1 | R8.41B |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.06 | $10.86 | 288.35% | 3 | $222.46M |
| ASRT | Assertio Holdings | Buy |
8
|
$0.92 | $3.50 | 226.09% | 2 | $88.49M |